Cell And Gene Therapy Supply Chain/Logistics: A Leading Driver Behind The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cell And Gene Therapy Supply Chain/Logistics Industry Market Size Be by 2025?
The market size of the cell and gene therapy supply chain/logistics has swiftly expanded in the past few years. The market, which will balloon from $1.41 billion in 2024 to $1.58 billion in 2025, boasts a compound annual growth rate (CAGR) of 11.8%. Factors responsible for the growth during the historical period include a surge in chronic disease prevalence, effective management of supply chain requirements, maintaining drug integrity, improved regulatory structures, and increased focus on reducing risk and enforcement of compliance.

What's the Long-Term Growth Forecast for the Cell And Gene Therapy Supply Chain/Logistics Market Size Through 2029?
Anticipated swift expansion is on the cards for the cell and gene therapy supply chain/logistics market in the upcoming years, with an estimated value of $2.44 billion by 2029 and a compound annual growth rate (CAGR) of 11.5%. This projected growth can be linked to the advent of personalized medicine, rise in cell-free therapies, increasing incidence of chronic illnesses, expanding global cell therapy manufacturing sector, along with effective adherence to supply chain prerequisites. Crucial trends during this predicted period will likely surface in the form of amplified spending on research and development, integration of state-of-the-art technologies, endorsed schemes and programs facilitating enhanced accessibility, strategic alliances and teamwork among cell and gene therapy corporations, supply chain entities, and logistics businesses, accompanied by the offering of tailored services to back all stages of patient identification.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

What Are the Key Growth Drivers Fueling the Cell And Gene Therapy Supply Chain/Logistics Market Expansion?
The escalating demand for cell and gene therapies is the propelling force behind the cell and gene therapy supply chain or logistics market growth. Cell and gene therapies, being cutting-edge medical treatments, manipulate cells or genes for disease treatment, providing possible breakthroughs for incurable conditions. The maintenance of appropriate storage temperature and conditions for these therapies is crucial, a feat made possible by the services of supply chain and logistics, which assist from procurement to distribution and storage of these cell and gene therapies. For example, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, notes a 10% growth in Phase III clinical trials of gene therapies in Q3 2023, marking the first rise since Q3 2022. Consequently, the growing demand for cell and gene therapies is steering the growth of the cell and gene therapy supply chain or logistics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp

What Are the Key Trends Driving Cell And Gene Therapy Supply Chain/Logistics Market Growth?
The increasing prevalence of contemporary technology platforms is a significant trend in the cell and gene therapy supply chain and logistics markets. Predominant businesses in this market are implementing these advanced technology platforms to maintain their market foothold. For example, in April 2023, AmerisourceBergen Corporation, an American healthcare business with a specialty in cell and gene therapy supply chain logistics, established the Cell and Gene Therapy (CGT) Integration Hub. Powered by AmerisourceBergen's groundbreaking customer relationship management (CRM) system, the CGT Integration Hub seamlessly integrates with the biopharma platform to enhance the monitoring of cell and gene therapies' development and delivery.

How Is the Cell And Gene Therapy Supply Chain/Logistics Market Segmented?
The cell and gene therapy supply chain/logistics market covered in this report is segmented -

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12631&type=smp

Which Companies Are Leading the Charge in Cell And Gene Therapy Supply Chain/Logistics Market Innovation?
Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

Which Regions Are Leading the Global Cell And Gene Therapy Supply Chain/Logistics Market in Revenue?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12631

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.